Beclometasone monodose nebuliser solution - Chiesi

Drug Profile

Beclometasone monodose nebuliser solution - Chiesi

Alternative Names: BDP UDV; Clenil A

Latest Information Update: 02 Sep 2016

Price : $50

At a glance

  • Originator Chiesi Farmaceutici
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma
  • No development reported Rhinosinusitis

Most Recent Events

  • 02 Sep 2016 No development reported - Phase-III for Rhinosinusitis (Adjunctive treatment) in Italy (Inhalation)
  • 24 Apr 2014 Chiesi completes the phase III CLEAR trial in acute Rhinosinusitis (adjunctive-treatment) in Italy (EudraCT2011-001459-35)
  • 31 Dec 2013 Launched for Asthma in China (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top